Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative 5-FU Regimens in Rectal Cancer
NCT00002551Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 1994
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of fluorouracil in rectal cancer (3 arms), sponsored by SWOG Cancer Research Network. Primary endpoints: Overall Survival and Relapse-Free Survival. Started Mar 1994; status: completed.
02
Drugs
fluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00002551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002551.